[Thrombophilia in early and late sclerosis].
D000367:Age Factors; D000925:Anticoagulants / Q000627:therapeutic use; D001158:Arteries / Q000378:metabolism; D001161:Arteriosclerosis / Q000150:complications* / Q000188:drug therapy / Q000378:metabolism; D004176:Dipyridamole / Q000627:therapeutic use; D006801:Humans; D050356:Lipid Metabolism; D009705:Nucleosides / Q000627:therapeutic use; D010208:Papaverine / Q000627:therapeutic use; D010958:Plasminogen / Q000378:metabolism; D012694:Serine / Q000378:metabolism; D013442:Sulfinpyrazone / Q000627:therapeutic use; D013925:Thromboplastin / Q000378:metabolism; D013927:Thrombosis / Q000188:drug therapy / Q000209:etiology*
D000925:Anticoagulants; D009705:Nucleosides; D012694:Serine; D004176:Dipyridamole; D010958:Plasminogen; D013925:Thromboplastin; D010208:Papaverine; D013442:Sulfinpyrazone
Die Thrombophilie bei Früh- und Spätsklerose.